Opthea Says Combination Therapy Candidate for Diabetes-Related Vision Loss Shows Potential in Phase 1B Study

Opthea表示用於糖尿病相關視力損失的組合治療候選藥物在第10億項研究中顯示出潛力

MT Newswires · 01/07 08:34

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文

登入/註冊

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Opthea Says Combination Therapy Candidate for Diabetes-Related Vision Loss Shows Potential in Phase 1B Study

Opthea Says Combination Therapy Candidate for Diabetes-Related Vision Loss Shows Potential in Phase 1B Study

風險及免責聲明

聲明